Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $169.00

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its price target boosted by equities researchers at Wells Fargo & Company from $163.00 to $169.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would indicate a potential downside of 0.47% from the stock’s current price.

A number of other analysts have also recently issued reports on the company. Oppenheimer raised Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 price objective for the company in a research report on Tuesday, January 21st. Morgan Stanley raised their price target on Hamilton Lane from $182.00 to $190.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. The Goldman Sachs Group downgraded shares of Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price objective on the stock. in a report on Monday, January 6th. JPMorgan Chase & Co. raised their target price on shares of Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Finally, UBS Group raised their price objective on shares of Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Hamilton Lane currently has a consensus rating of “Hold” and an average price target of $171.71.

Get Our Latest Report on HLNE

Hamilton Lane Stock Performance

NASDAQ HLNE traded up $8.40 on Wednesday, hitting $169.80. 147,481 shares of the stock were exchanged, compared to its average volume of 397,202. The company has a market capitalization of $9.41 billion, a PE ratio of 36.76 and a beta of 1.25. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 3.37. The business’s fifty day moving average is $160.49 and its 200 day moving average is $162.75. Hamilton Lane has a 52 week low of $103.42 and a 52 week high of $203.72.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last issued its earnings results on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.12. Hamilton Lane had a net margin of 28.03% and a return on equity of 35.59%. The company had revenue of $168.26 million for the quarter, compared to analysts’ expectations of $158.86 million. During the same period in the prior year, the firm earned $0.71 EPS. Hamilton Lane’s quarterly revenue was up 34.3% compared to the same quarter last year. Research analysts anticipate that Hamilton Lane will post 4.88 EPS for the current fiscal year.

Hedge Funds Weigh In On Hamilton Lane

A number of hedge funds have recently added to or reduced their stakes in HLNE. CWM LLC increased its position in shares of Hamilton Lane by 24.7% in the third quarter. CWM LLC now owns 505 shares of the company’s stock worth $85,000 after purchasing an additional 100 shares during the period. GAMMA Investing LLC increased its holdings in Hamilton Lane by 32.4% in the 3rd quarter. GAMMA Investing LLC now owns 637 shares of the company’s stock valued at $107,000 after buying an additional 156 shares during the period. Icon Wealth Advisors LLC bought a new stake in shares of Hamilton Lane during the 3rd quarter worth approximately $111,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Hamilton Lane during the 3rd quarter worth approximately $127,000. Finally, KBC Group NV increased its stake in Hamilton Lane by 18.0% in the third quarter. KBC Group NV now owns 1,141 shares of the company’s stock valued at $192,000 after acquiring an additional 174 shares during the last quarter. Institutional investors own 97.40% of the company’s stock.

Hamilton Lane Company Profile

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

See Also

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.